Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05585320
Title A Phase 1/2a Study of IMM-1-104 in Participants With Previously Treated, RAS-Mutant, Advanced or Metastatic Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Immuneering Corporation
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope RECRUITING Duarte California 91010 United States Details
University of California San Diego NOT_YET_RECRUITING San Diego California 92037 United States Details
Sarcoma Oncology Center RECRUITING Santa Monica California 90403 United States Details
Florida Cancer Specialists and Research Institute RECRUITING Lake Mary Florida 32746 United States Details
Northwestern University RECRUITING Chicago Illinois 60611 United States Details
Dana Farber Cancer Institute RECRUITING Boston Massachusetts 02215 United States Details
Hematology Oncology Associates of Central New York RECRUITING East Syracuse New York 13057 United States Details
Weill Cornell Medicine RECRUITING New York New York 10021 United States Details
Duke University Cancer Institute NOT_YET_RECRUITING Durham North Carolina 27710 United States Details
SCRI Oncology Partners RECRUITING Nashville Tennessee 27203 United States Details
MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
NEXT Oncology RECRUITING San Antonio Texas 78229 United States Details
NEXT Oncology RECRUITING Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field